Community Forum Archive

The Epilepsy Community Forums are closed, and the information is archived. The content in this section may not be current or apply to all situations. In addition, forum questions and responses include information and content that has been generated by epilepsy community members. This content is not moderated. The information on these pages should not be substituted for medical advice from a healthcare provider. Experiences with epilepsy can vary greatly on an individual basis. Please contact your doctor or medical team if you have any questions about your situation. For more information, learn about epilepsy or visit our resources section.

Please, can you send me more information

Mon, 07/02/2007 - 16:26
Please, can you send me more information about test medical product "Carizmate"? Thank's advance! blue_g@abv.bg

Comments

Re: Please, can you send me more information

Submitted by Anonymous on Mon, 2007-07-09 - 08:55
I've sent your request on...

Re: Re: Please, can you send me more information

Submitted by Anonymous on Mon, 2007-07-09 - 11:09
Are you referring to carisbamate? This is a new drug being tested for epilepsy by Johnson & Johnson. There are published articles in the medical literature about early work on this drug and clinical trials going on now. Looks like it is being tested for use in partial seizures and for the treatment of postherpetic neuralgia.

Visit www.clinicaltrials.gov or the clinical trials page here to see what is going on in your area.

www.clinical trials.gov

epilepsy.com clinical trials page

Hope this helps!

Epi_help

Visit www.clinicaltrials.gov or the clinical trials page here to see what is going on in your area.

www.clinical trials.gov

epilepsy.com clinical trials page

Hope this helps!

Epi_help

Hi, thank you for answer

Submitted by blue_g on Mon, 2007-07-16 - 05:43
Hi, thank you for answer ;o) Yes, the drug is the same. Thank's and be happy ;o)

Sign Up for Emails

Stay up to date with the latest epilepsy news, stories from the community, and more.